Scleroderma Registry & Repository at the Hospital for Special Surgery
ConditionScleroderma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital for Special Surgery, New York
About this trial
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Eligibility criteria
Qualifiers
Individuals older than 18 years of age with Scleroderma
Disqualifiers
Individuals younger than 18 years of age
Individuals older than 18 years of age without Scleroderma
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov